Publisher: FirstWord Published: Last 3 Years-
Evaluating the Peterson Health Technology Institute’s Role in Shaping Digital Health Technology Assessments and Payer Impact
Evaluating the Peterson Health Technology Institute’s Role in Shaping Digital Health Technology Assessments and Payer Impact As many new promising digital health tech solutions enter the market, agencies like the Peterson Health Technology Institute (PHTI) have begun independent, evidence-based eval ... Read More
-
The Power of Predictive Analytics in Pharma Marketing
The Power of Predictive Analytics in Pharma Marketing Discover how predictive analytics is transforming pharmaceutical marketing in our latest report, The Power of Predictive Analytics in Pharma Marketing. By leveraging advanced algorithms and big data, predictive analytics can forecast customer beh ... Read More
-
Need some help finding the right information ?Verify before you buy
or call us
US toll free: 800.298.5699
Worldwide: +1.240.747.3093
-
How AI Will Shape the Future Of Pharma Marketing
How AI Will Shape the Future Of Pharma Marketing Explore the transformative impact of generative artificial intelligence and machine learning on pharmaceutical marketing with our comprehensive report. This detailed analysis delves into how AI is revolutionising drug discovery, development and commer ... Read More
-
Cybersecurity: The next hurdle for pharma to navigate
Cybersecurity: The next hurdle for pharma to navigate Explore the escalating cybersecurity challenges faced by the pharmaceutical industry, including the sector's vulnerability due to valuable intellectual property and sensitive patient data. This report delves into the evolving threat landscape, th ... Read More
-
Sales Rep Metrics: Best Practice for Measuring Success
Sales Rep Metrics: Best Practice for Measuring Success Explore the evolving role of pharmaceutical sales representatives in today’s dynamic market, highlighting the new skills essential for success. This comprehensive report analyses both qualitative and quantitative metrics for effectively measurin ... Read More
-
Opportunities for AI to Elevate Medical Information Strategy
Opportunities for AI to Elevate Medical Information Strategy The drive for medical affairs to personalise content for health care practitioners (HCPs) could be enabled by AI, but just how far can AI be used? Our latest report, Opportunities for AI to Elevate Medical Information Strategy, delves into ... Read More
-
Innovative Pricing Strategies for Cell and Gene Therapies: The Pharma Company View
Innovative Pricing Strategies for Cell and Gene Therapies: The Pharma Company View Our latest report, Innovative Pricing Strategies for Cell and Gene Therapies: The Pharma Company View, delves into the evolving landscape of reimbursement models for gene and cell therapies, highlighting the stark con ... Read More
-
Harnessing AI Capabilities to Disrupt Current P&R Models
Harnessing AI Capabilities to Disrupt Current P&R Models Enhancing Pricing and Reimbursement Strategies by Leveraging AI Capabilities Discover how Artificial Intelligence (AI) is revolutionising the pharmaceutical industry's approach to pricing and reimbursement (P&R) in our latest report, Harnessin ... Read More
-
Best practice in decentralised trials
Best practice in decentralised trials By removing logistical barriers, decentralised clinical trials (DCTs) offer time and cost savings, improved patient access, and more diverse and representative populations. Our latest report, Best Practices in Decentralised Trials, delves into the potential of d ... Read More
-
Redesigning digital health go-to-market models to align with drug commercialisation models
Redesigning digital health go-to-market models to align with drug commercialisation models Redefining Market Strategies: Digital Health Meets Pharma Discover how aligning digital health go-to-market (GTM) models with traditional drug commercialisation strategies can revolutionise market success. Our ... Read More
-
Pricing and Reimbursement of Pharmaceuticals in the US: A data-driven analysis (2024)
Pricing and Reimbursement of Pharmaceuticals in the US: A data-driven analysis (2024) Navigating the Complexities of US Drug Pricing & Reimbursement Explore the intricacies of pharmaceutical pricing and reimbursement in the US with our latest report, Pricing and Reimbursement of Pharmaceuticals in t ... Read More
-
Digital-first Sales Strategies: Why change is needed
Digital-first Sales Strategies: Why change is needed Embracing the Digital Shift in Pharma Sales Explore the transformation of pharma sales in our latest report, Digital-first sales strategies: Why change is needed. This analysis highlights the shift from traditional to digital strategies, emphasisi ... Read More
-
Digital Health: Overcoming Key Challenges
Digital Health: Overcoming Key Challenges Practical strategies to overcome digital health development and deployment challenges From improving clinical research efficiency to better understanding the patient’s experience, digital health technology is touching every aspect of pharma’s business. Howe ... Read More
-
Building Trust Through Influencer Marketing
Building Trust Through Influencer Marketing How to leverage the power of social media influencers to drive marketing gains Cost-effective influencer marketing is becoming critical to pharma’s outreach strategy. It allows companies to extend their reach, build credibility, educate patients, and incre ... Read More
-
Leveraging AI Technology for Go-to-Market Strategy Decisions
Leveraging AI Technology for Go-to-Market Strategy Decisions Revolutionising go-to-market strategies through AI technologyDive into the transformative power of AI in pharmaceutical go-to-market (GTM) strategies with our latest report, Leveraging AI Technology for Go-to-Market Strategy Decisions. Unc ... Read More
-
Communicating Value to External Stakeholders: Insights for Medical Affairs
Communicating Value to External Stakeholders: Insights for Medical Affairs Practical Medical Affairs strategies for proving value to patients, payers, HCPs and regulators Stakeholders want evidence of value, but what is value? Medical Affairs teams are leveraging RWE and digital technology to define ... Read More
-
Tomorrow’s MSLs
Tomorrow’s MSLs Explore the evolving role of MSLs in the dynamic landscape of healthcare and pharmaceuticals Discover the future of Medical Science Liaisons (MSLs) in our latest report, Tomorrow's MSLs. This report delves into the evolving role of MSLs within the pharmaceutical industry, highlightin ... Read More
-
Leveraging Real-World Data with AI to Enhance Comparative Effectiveness Research
Leveraging Real-World Data with AI to Enhance Comparative Effectiveness Research How AI-enabled RWD analysis can take your Comparative Effectiveness Research to the next level How are AI-enabled tools transforming the use of real-world data (RWD) in Comparative Effectiveness Research (CER)? Advanced ... Read More
-
Payer Perspectives on Digital Health
Payer Perspectives on Digital Health How to win payer support for digital health solutions Accelerated by the COVID-19 pandemic, both patients and physicians have bought into the convenience offered by virtual health technologies. So, how have payers responded? While many have initiated virtual hea ... Read More
-
Leveraging Patient-Reported Outcomes for Drug Development and Commercial Success
Leveraging Patient-Reported Outcomes for Drug Development and Commercial Success How to harness the power of patient-reported outcomes to drive clinical research and commercial gains From refining clinical study design to informing HTA reviews and commercial decision-making, increasingly influential ... Read More
-
Biosimilars: US Payer Perspectives
Biosimilars: US Payer Perspectives Establishing biosimilar interchangeability, patent litigation, negative stakeholder attitudes, poor discounts, and defensive originator strategies have underpinned the sluggish development of the US biosimilar market. So, what would payers like to see? Will adalimu ... Read More
-
Generative AI impact on the pharmaceutical business model
Generative AI impact on the pharmaceutical business model Few digital technologies are generating as much excitement as Generative AI (GenAI) – but how and where will it deliver the best value for pharma? Adherents say GenAI has wide potential, from drug discovery and personalised medicine through t ... Read More
-
Harnessing technology to map the rare disease patient journey continuum
Harnessing technology to map the rare disease patient journey continuum Patient journey mapping is critical to understanding the real-world experience of rare disease patients and can inform pharma's commercial outlook and research programs. Expanding digital health technologies transform patient jo ... Read More
-
Leveraging AI to unlock commercial insights from HCP prescribing_claims data
Leveraging AI to unlock commercial insights from HCP prescribing_claims data Electronic Medical Records (EMR) are a treasure trove of critical information for pharma, from understanding the patient journey and optimising medicines to tracking prescribing habits and unlocking competitor intelligence. ... Read More
-
Understanding and Communicating the Strengths and Weaknesses of RWE for Market Access
Understanding and Communicating the Strengths and Weaknesses of RWE for Market Access Real-world evidence (RWE) provides stakeholders with a more holistic view of a product’s potential and informs market access decision-making. But RWE can be based on a variety of real-world data sources, each with ... Read More
Research Assistance